ArticleJournal of translational medicine2021

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer.

M Janusz Mezynski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.